SHANGHAI ARCHIVES OF PSYCHIATRY INSTRUCTIONS TO AUTHORS

(February 2014)

SHANGHAI ARCHIVES OF PSYCHIATRY INSTRUCTIONS TO AUTHORS

(February 2014)

TheShanghai Archives of Psychiatryis a general psychiatry journal published bimonthly by the Shanghai Mental Health Center of Shanghai Jiao Tong University Medical Center. Starting publication in 1959, it was China’s first specialty psychiatry journal and is currently one of the core psychiatry journals published in China. Starting with the first issue of 2012 all the content in the journal has been published in English, with Chinese-language translations of the abstracts of original articles. Starting with the last issue of 2013, a Chinese translation of each English-language issue has been provided free of charge on the journal’s website one month after publication of the English-language version. Papers can be submitted in Chinese or English; Chinese papers will be translated by journal staff and lineedited by native speakers of English. TheShanghai Archives of Psychiatryconsiders manuscripts on the full range of topics relevant to mental health in China and elsewhere, including research in the basic neurosciences, clinical practice, epidemiology, and health services. We welcome original papers on new research and secondary analyses that report on new aspects of high-quality studies that have been published previously. We also consider reviews, meta-analyses, papers on biostatistical and methodological issues relevant to psychiatry, commentaries and letters about previously published research, and forum pieces that discuss different viewpoints on controversial issues of interest to mental health professionals. TheShanghai Archives of Psychiatryis an open-access journal, doi versions of all articles that are accepted are immediately placed on our website (www.saponline.org) and can be downloaded free of charge. If authors have questions about a potential submission that are not covered in the following instructions, they should contact the editorial staff at shtougao3296@163.com.

1. TYPES OF MANUSCRIPTS

1.1 Original articles.

As described below in section 3, the structure and content of original research articles varies somewhat based on the topic. Generally speaking the main text (including introduction, methods, results and discussion) should be under 4500 words, and there should be no more than 5 tables or figures and less than 30 references. Original articles should include a structured abstract of less than 350 words (see section 3.4) and 3 to 6 key words that conform to MeSH (Medical Subject Headings) requirements (http:// www.nlm.nih.gov/mesh/).

1.2 Reviews.

These are comprehensive reports on the current state of knowledge about a topic of current theoretical, clinical or public health significance. We are particularly interested in reviews that summarize and interpret the research or clinical practices in China and put it in its international context. Transparency about the material included in reviews is essential, so all reviews should include brief sections entitled ‘Search strategy and selection criteria’ stating the sources of the material covered and the criteria used to include or exclude studies. Reviews should be under 5000 words and have at least 50 references. Reviews should include an unstructured summary of less than 250 words and 3 to 6 key words that conform to MeSH requirements (http://www.nlm.nih.gov/mesh/). Authors interested in preparing reviews should contact the editors BEFORE writing the review to ensure that the topic will be of interest to our readership.

1.3 Systematic reviews and meta-analyses.

We are particularly interested in meta-analyses that pool data from studies published in both Chinese and English, as most meta-analyses in international journals do not include studies published in Chinese. Metaanalyses papers need to include a flowchart of the search strategy to identify included papers, a league table with a description of the characteristics of the included studies (sorted by year of publication), forest plots of the main results and (if there are 10 or more included studies) a funnel plot of the distribution of results to identify potential publication bias. These papers also need to include a formal criticalappraisal of the quality of the evidence in the included studies; we recommend authors use the GRADE approach (Guyatt GH et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.BMJ. 2008; 336 (7650): 924-926). It is also important to include an assessment of the heterogeneity of the reported results and a sensitivity analysis to identify outlier results. Systematic reviews and meta-analyses should include an unstructured summary of less than 250 words and 3 to 6 key words that conform to MeSH requirements (http://www.nlm.nih.gov/mesh/). Individuals who have questions about writing a meta-analysis paper should contact the Meta-analysis Editor, Professor Chunbo LI (chunbo_li@163.com).

1.4 Commentaries.

These are detailed discussions about research articles published in theShanghai Archives of Psychiatryby Chinese and international experts who were not involved in the original research. They can consider the methodological issues raised by the original article, the implications of the report, or provide the details of other on-going research projects related to the original report. Commentaries should be under 2000 words in length, include no more than 2 tables or figures and have less than 15 references.

1.5 Forums.

These papers present a particular point of view on a controversial topic in mental health. They can involve scientific, clinical or policy issues. The manuscripts should be 1000 to 2000 words in length and have less than 20 references. In each issue two or more papers with varying viewpoints on a topic of interest by Chinese and international experts will be placed in the ‘Forum’ section of the journal. Authors interested in preparing a manuscript for the Forum section should contact the editors BEFORE they prepare the paper; if we think the topic of sufficient interest we will recruit other experts to write papers with alternative

viewpoints about the topic.

1.6 Correspondence.

Readers are encouraged to write letters of less than 1000 words with no more than 5 references and no more than one table or figure. Letters will usually discuss some aspect of the research, commentaries, forums or other content previously published in the journal, but they can also briefly present data from

studies or raise other areas of interest to readers.

1.7 Case reports.

These are single cases or case series that highlight an interesting or important clinical or theoretical issue. We are particularly interested in case reports that highlight specific characteristics of patients in China or specific aspects of the Chinese mental health care system. Case reports should be less than 1500 words in length, include no more than one table or figure and have less than 10 references. Case reports should include an unstructured summary of less than 150 words and 3 to 6 key words that conform to MeSH requirements (http://www.nlm.nih.gov/mesh/). Submissions for case reports must include a copy of the signed consent form from the patient(s) described in the report.

1.8 Biostatistical methods in psychiatry.

The journal has a regular column entitled ‘Biostatistics in Psychiatry’ that is coordinated by our three biostatistics editors: Ying LU (ying.lu@va.gov); Xin TU (xin_tu@urmc.rochester.edu); and He HUA (hua_ he@urmc.rochester.edu). The section describes different statistical methods that are relevant to analyses in psychiatric research. The articles should be no longer than 2000 words, include practical examples of how to conduct the analytic methods being described, and be written for a general research audience (not solely for biostatisticians). Biostatistical submissions should include an unstructured summary of less than 200 words and 3 to 6 key words that conform to MeSH requirements (http://www.nlm.nih.gov/mesh/). Individuals interested in contributing a piece to this section should contact one of the biostatistical editors.

1.9 Research methods in psychiatry.

Our journal is committed to continually improving research methods in psychiatry, to promoting the use of evidence-based methods in the treatment of mental disorders, and to introducing novel methodological approaches to the psychiatric research community. To this end we intend to develop a ‘Research Corner’column, so we encourage submissions that describe new research methods or novel approaches to resolving long-standing problems in current research methods for all types of research including but not limited to basic animal studies, clinical studies, large-scale epidemiological studies, and policy studies.Articles should be no longer than 2500 words and have no more than 30 references. Submissions about research methods should include an unstructured summary of less than 200 words and 3 to 6 key words that conform to MeSH requirements (http://www.nlm.nih.gov/mesh/). Authors interested in contributing papers to the Research Corner should contact Dr. Hui CHENG (chengyaojin@yahoo.com).

2. GENERAL INFORMATION FOR PREPARATION OF ALL TYPES OF MANUSCRIPTS

Writing in all manuscripts should be clear and concise with no unnecessary use of technical terms or abbreviations, making the manuscripts accessible to all mental health professionals not only to those who work in a particular field. This section lists general issues relevant for all manuscripts; the next section provides more detailed information about preparing original articles.

2.1Language of submission.

Manuscripts can be submitted in either Chinese or English. All Chinese-language manuscripts will be translated by the Journal office and line-edited by native English speakers. Once the final English-version of each issue is approved the entire issue is translated into Chinese by the Journal office. The Chineselanguage abstracts of original articles and summaries of reviews, systematic reviews, meta-analyses, case reports and articles about biostatistical or research methods are included in the English-language version of each issue. The complete Chinese-language translation of each issue is published in electronic form on the Journal’s website one month after the English-language version is released.

2.2 Formatting of the manuscript.

With some exceptions, theShanghai Archives of Psychiatryfollows the style recommendations of the Royal College of Psychiatrists House Style manual which can be freely downloaded at: (http://www. rcpsych.ac.uk/pdf/RCPSychHouseStyle-Sep11.pdf). Manuscripts should be submitted in Word format (i.e.,‘manuscript.doc’ or ‘manuscript.docx’). Single spacing should be used in the text but main sections and subsections within the text should be divided by empty lines to facilitate reading. The main text should use 10.5-point Calibri typeface, but smaller gauge Calibri typeface can be used in tables if necessary. Chineselanguage manuscripts should use standard simplified Chinese characters in number 5 ‘hua wen xi hei’ (华 文 细 黑 ) typeface. The typeface used to distinguish primary, secondary and tertiary levels within the manuscript should be different and used consistently throughout the text. The heading of a main section or a subsection (level 1 and level 2) should be in bold and written on a separate line; the heading for a sub-sub heading (i.e., level 3 heading) should be initalic, not using bold, and on a separate line. The title page, abstract, main text, and each figure and table should begin on a separate page in the manuscript. Whenever possible, figures and tables should be placed at the end of the main document (after the references) rather than being submitted as separate documents. All pages of the manuscript should be sequentially numbered starting 1,2,3 and so forth. If a manuscript is accepted, authors will be expected to submit high-definition versions of figures and the original data for any graphs so that figures and graphs can be formatted to Journal style.

2.3Title.

Many electronic searches are based on titles so the title should clearly describe the main content of the paper. Avoid abbreviations and empty words (e.g., 'research study', 'discussion of') in the title.

2.4 Authors.Only persons who made a substantial contribution to the work should be listed. This should generally be six or fewer. Do not list a ‘research group’ as the author, though a few authors could be the representatives of a ‘research group’, the members of which are listed in the acknowledgment section. The order of the authors and the person assigned as the corresponding author needs to be determined at the time of submission, they cannot be changed later. The journal can occasionally accept two ‘co-first authors’ or two ‘co-corresponding authors’ but the reason for this needs to be explained in the cover letter for the manuscript to the editor. We will not accept more than two first authors or more than two corresponding authors.

2.5 Institutional affiliations.

The institution where the first author worked at the time of completing the work reported in the manuscript should be the primary institutional affiliation reported in the manuscript. If the first authorcurrently works at a different institution or if the first author was a trainee from another institution at the time of completing the reported work the current institution or the home institution can also be noted as secondary institutional affiliations of the first author, but should not be identified as the primary institution for the first author of the manuscript.

2.6Abstracts and summaries.

Original articles should have structured abstracts of less than 350 words (see Section 3.4 below). Reviews, systematic reviews and meta-analyses should have unstructured summaries of less than 250 words; papers about biostatistical or research methods should have unstructured summaries of less than 200 words; and case reports should have unstructured summaries of less than 150 words. Commentaries, forums and correspondence do not have summaries.

2.7 Key words.

A list of 3 to 6 key words should follow the abstract or summary of all original articles, reviews, systematic reviews, meta-analyses, case reports, and papers on biostatistical or research methods. These words are what PubMed and other electronic databases use to classify each article so authors need to select their key words carefully from those available at the Medical Subject Headings (MeSH) website which is maintained and regularly updated by the United States National Library of Medicine (http://www.nlm.nih. gov/mesh/). Authors can check if specific words or terms they would like to use as key words are included under MeSH by visiting the ‘MeSH Browser’ website: http://www.nlm.nih.gov/mesh/MBrowser.html. See the following page for instructions on how to use the MeSH Browser: http://www.nlm.nih.gov/mesh/ authors.html

2.8References.Only references directly relevant to the content of the manuscript that the authors have read in FULL should be listed; copying references from other papers or referring to articles only seen in abstract is not acceptable. Authors must carefully check the information in the reference against the original to ensure accuracy. Numbered references should appear sequentially in the text. In the text the number or numbers of the reference(s) cited should appear as superscripts in square brackets (for example;[2-3,6]) . If a reference only appears in a table or a figure the sequence number for the reference should be the number that would be appropriate for text that appears at the point the table or figure is first mentioned in the text. Unpublished materials should not appear in the reference list unless there is a doi number or other website at which readers can obtain the material.

Authors’ names are written with the surname followed by one or more capitalized initials for the given name(s); different authors’ names are separated by commas. To facilitate our readers access to the references employed in an article, a digital object identifier (doi) number (or other web address) should be included in the reference for all articles that have a doi or are available at other websites.

Loo CK, Mitchell PB. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy.J Affect Disord. 2005; 88(3): 255-267. doi: http://dx.doi.org/10.1016/j.jad.2005.08.001

should be provided in the original language, NOT translated into English. Thus, for manuscripts submitted in English references to Chinese materials should be written in Chinese and references in other non-English languages should be written in the original language. Similarly, for manuscripts submitted in Chinese, references to English-language materials should be written in English and references to Chinese-language materials should be written in Chinese.

References to Chinese materials should be written in the same format as English-language references with the exception that the full Chinese name of authors is provided and the names of Chinese journals are written out in full in Chinese (NOT in English). For example:

付登礼 ,何梅 . 关于性别重塑手术的伦理问题的研究综述 . 中国医学伦理学 . 2002; 16(3): 20-22. doi: http://dx.doi.org/10.3969/j.issn.1001-8565.2002.03.010

If a reference has more than six authors, the first six are listed followed by ‘et al.’ for English-language materials and by ‘等 ’in Chinese-language materials. Authors should not simply copy references from other publications, because these often employ different formats. Authors should be particularly careful in writing the abbreviated titles of English-language journals; the correct abbreviations for journal titles are provided at the following website: http://www.ncbi.nlm.nih.gov/nlmcatalog/journals.

Examples of references of English materials:

Journal article: Phillips MR, Zhang JX, Shi QC, Song ZQ, Ding ZJ, Pang ST, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey.Lancet. 2009; 373(9680): 2041-2053. doi: http://dx.doi.org/10.1016/ S0140-6736(09)60660-7

Book: American Psychiatric Associaon.Washington: American Psychiatric Associaon; 1994.

Chapter in a book: Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors.The Genetic Basis of Human Cancer. New York: McGraw-Hill; 2002. p. 93-113.

Monograph (document) on the internet: Foley KM, Gelband H, editors. Improving palliave care for cancer [Internet]. Washington: Naonal Academy Press; 2001 [cited 2002 Jul 9]. Available from: hp://www.nap.edu/books/0309074029/ html/.

Part of a homepage/Website:

American Medical Association [Internet]. Chicago: The Association; c1995-2002 [updated 2001 Aug 23; cited 2002 Aug 12]. AMA Office of Group Practice Liaison; [about 2 screens]. Available from: http://www.ama-assn.org/ama/pub/category/1736.html.

For types of materials that are not covered by the above examples, theShanghai Archives of Psychiatryemploys the standard method for referencing recommended by International Committee of Medical Journal Editors (ICMJE) Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.nlm.nih.gov/bsd/uniform_requirements.html). Authors should check this website for examples of how to compose references in other types of situations. If in doubt about how to compose a reference, authors could also check reference lists from articles in recent issues of theShanghai Archives of Psychiatry.

2.9 Figures.

Figures should be self-explanatory and abbreviations used should be explained in footnotes. If at all possible figures should be inserted in the Word document with the main manuscript rather than being supplied as a separate document in a different format. Figures are numbered sequentially as they appear in the text, if there is only one figure it is labeled ‘Figure 1’. The title for a figure should appear above the figure. All graphs and figures will be edited prior to publication so, if a manuscript is accepted, authors will subsequently be expected to submit high-resolution versions of their figures and graphs that can be edited

by the editorial staff.

2.10 Tables.

Tables should be composed using the ‘Tables’ function in WORD rather than by importing it from Excel, SPSS or some other format. The title and footnotes should be part of the table, not separate from the table; they are the top and bottom lines of the WORD table that have merged all cells across the width of the table, allowing the title and footnote content to be moved as the table is move or re-formatted. We prefer to publish all tables on vertical pages; these tables can have a maximum of 90 characters (including spaces). If a table has many columns and cannot be conveniently broken down to separate vertical tables it can be presented on a horizontally oriented page, but it should never be wider than the maximum 150 characters (including spaces). All tables should be numbered sequentially as they appear in the text; if there is only one table, it is labeled ‘Table 1.’ Tables should be self-explanatory so that readers can understand the content of the table without reference to the text. All abbreviations used in tables should be explained in footnotes. All tables should indicate the actual numbers of cases on which the results are based (i.e., do not present percents or means without specifying the denominator on which they are based in a parenthesis beside the statistic, in the column title, or in a footnote). It is generally better to present specific P-values in separate columns of a table rather than categorizing P-values a ‘p＜0.05,p＜0.01,p＜0.001’. The number of significant digits for the figures within a column should be the same (thatis, write ‘0.030, 0.300, 0.311’ NOT ‘0.03, 0.3, and 0.311’). For Tables that are reprints or adapted versions of previously published tables, the original publication of the table should be cited in the footnote (and in the reference list).

2.11 Units of measurement.

When preceded by a number, units of time use the following symbols: ‘d’ (days), ‘h’ (hours), ‘min’(minutes), ‘s’ (seconds). There is no plural form for the symbols representing units of measurement; for example, write ‘23 min’ NOT ’23 mins’. A unit of measurement may combine physical and non-physical entities; for example, ‘times/min’, ‘persons/year’, and so forth. If there are more than one dividing entity in a unit of measurement it should be written using units to the power of -1; for example, ‘ng·kg-1·min-1’ NOT‘ng/kg/min’. The units for standard deviations of a parameter do not need to be repeated if the standard deviation is reported with the mean in the mean (sd) format; for example, ‘4.5 (1.2) times/d’ NOT ‘4.5

times/d (1.2 times/d)’. The gap between a number and a unit should be a hard space (ctrl+shift+space).

2.12 Numerals.Dates should always be based on the Gregorian calendar. Dates should be written as ’23 August 2013’ not‘August 23, 2013’. All numbers are written as Arabic numerals. For numbers with many digits, four-digit numbers are written without any additional editing (e.g., ‘5783’) but for numbers with five or more digits every three digits before the decimal is separated by a hard comma (that is, a comma that cannot be at the end of a line of text); for example ‘5,678,430.01543’. Decimal numbers must always have a ‘0’ preceding the decimal; for example, ‘0.143’ NOT ‘.143’. When writing a range of numbers in the text the word ‘to’ is used between the numbers; for example, ’the range in scores was 23 to 45’ not ’23-45’. In tables the range of numbers (e.g., in a confidence interval) is separated by a hyphen (e.g., 95% CI = 0.45-0.79)unlesseither number is a negative value in which case a tilde is used (e.g., 95% CI=-7.2 ～ -5.4; CI=-4.2 ～ 2.5). When using the percent symbol in a sequence or range the symbol should not be repeated; for example, ’10 to 20%’NOT ’10% to 20%’. When the mean and standard deviation of a percent value is presented, the % symbol should follow the parenthesis; for example ‘54.2 (12.4)%’ NOT ’54.2% (12.4%)’. When multiplying units of length, the unit of measurement should be repeated with each number; for example, ‘4 cm X 3 cm X 5 cm’NOT ‘4X3X5 cm3’.

2.13 Statistics.

The symbols for the t-test (t), F-test (F), Chi Square test (χ2), correlation coefficient (r), degrees of freedom (df), probability (p) and other statistical tests or measures should all be written in italics. Do NOT use thesymbol to identify standard deviations as it implies symmetry around the mean that may not be the case; the standard deviation of a mean should usually be expressed as a number in parenthesis following a mean value; for example, ‘75.2 (13.5)’ or in a separate column in a table beside a column with the corresponding means. Do not report p-values without indicating the value for the corresponding statistical test and (in most cases) the degrees of freedom. Degrees of freedom can be written in three ways: ‘t=1.98,df=32’, ‘t(32)=1.98’ or ‘t32=1.98’. P-values should be preceded by a ‘0’ and written to three significant digits; for example, ‘p=0.120’, NOT ‘p=.120’, and NOT ‘p=0.12’. If the p-value is less than 0.001 it should be written‘p＜0.001’, NOT as ‘p=0.000’. For results that meet predetermined criteria of statistical significance, the statement in the text should be ‘…the result was statistically significant..’, NOT ‘..the result was significant’, and NOT ‘…the result was very significant’.

2.14 Abbreviations.

Abbreviations should not appear in the title and should be used sparingly in the text. Authors should limit the use of abbreviations, particularly in the abstract; in cases where a term only occurs once or twice in the abstract or in the main text there is no need to include the abbreviation. Three-letter abbreviations for the names of months (e.g., ‘Jan’, ‘Feb’, Mar’, ‘Apr’, etc.) can be used in tables and figures. In Chineselanguage text the first appearance of any abbreviations must give the full term in Chinese followed by a parentheses with the FULL term in English followed by a comma and then the abbreviation that will be used subsequently; for example, ‘简 明 精 神 病 评 定 量 表 (Brief Psychiatric Rating Scale, BPRS)’. In English-language text in the first instance the full term is written out followed by a parenthesis with the abbreviation that will be used subsequently; for example, ‘Hamilton Depression Rating Scale (HAMD)’. Some readers will not be familiar with abbreviations commonly used in psychiatric publications such as‘DSM-IV’, ‘WHO’, ‘ICD-10’, ‘BPRS’ and so forth; for this reason ALL abbreviations need to be written out intheir first appearance in the text. If an abbreviation appears in the Abstract and in the main text it needs to be written out fully the first time it appears BOTH in the abstract and in the main text; thus if it only appears once or twice in the abstract it would be better to use the full term (without the abbreviation) in the abstract and reserve the use of the abbreviation for the main text. Abbreviations that appear in tables or figures must be explained in the footnote of the table or figure, even if the full name is provided in the main text.

2.15 Drug names.

Only generic drug names should be used unless there is a specific reason to use the proprietary name.

3. SPECIFIC INFORMATION ABOUT PREPARATION OF ORIGINAL RESEARCH ARTICLES

All of the issues raised in the previous section are relevant for the preparation of manuscripts reporting original research results. The following points provide additional information specific to the preparation of original research articles.

3.1. Information that should be included in original research articles.

The information readers need to know about the conduct of a research study in order to evaluate the internal and external validity of the study (and, thus, decide whether or not the results are important) varies depending on the type of study. There are, therefore, different internationally accepted guidelines and checklists describing the information that should be included when reporting different types of studies, including guidelines for randomized controlled trials (CONSORT guidelines), observational studies (STROBE guidelines), genetic association studies (STREGA guidelines), studies of diagnostic accuracy (STARD guidelines), systematic reviews and meta-analyses (PRISMA guidelines), and meta-analyses of observational or epidemiological studies (MOOSE guidelines). The most recent versions of each guideline is available at the following website: http://www.equator-network.org/. Researchers should consider these guidelines when designing their studies (to ensure that all the necessary information is collected) and when preparing their research reports. Reviewers forShanghai Archives of Psychiatrywill consider these guidelines when assessing a manuscript, so authors are strongly advised to be familiar with the guidelines related to the type of study they plan to conduct.

3.2 Overall structure of manuscripts for original articles.

All authors of biomedical research reports should be familiar with the widely accepted requirements of reporting research. The most authoritative and detailed description of these requirements is theUniform Requirements for Manuscripts Submitted to Biomedical Journals(www.ICMJE.org). Our journal abides by these requirements. Manuscripts for original research articles submitted to theShanghai Archives of Psychiatryshould be organized as shown on the left.

All manuscripts need to have these sections unless there are no acknowledgments, figures, tables or appendices, in which case the corresponding section is omitted. The main text (Introduction, Methods, Results and Discussion) can be further divided into additional numbered level-two subsections (e.g., 2.1, 2.2, 2.3...) or level-three sub-subsections (such as 4.2.1, 4.2.2, 4.2.3…) if needed, but the subsections and sub-subsections in each major section (Introduction, Methods, Results and Discussion) should be limited to 5 or 6 at most.

3.3 Title page. (If possible limit it to a single page)

Includes title, authors, institutional affiliations of the authors, and the name and contact information (e-mail and cell phone) for the first author, the corresponding author and the author or other individual responsible for the statistical analysis used in the paper. Wherever possible titles should include the design employed in the study (e.g., randomized controlled trial; case-control study; cohort study, crosssectional study; meta-analysis, etc.). In Chinese-language manuscripts the formal English-language name of the participating institutions must be provided to prevent inaccurate translation of these Chinese location names. Only persons who make a substantial intellectual contribution to the study should be named authors; individuals who organized funding or run the center where the study is conducted but did not directly participate in the study should NOT be named authors (though they can be mentioned in the acknowledgements). The corresponding author is not, as is commonly the case in China, an honorary position for the primary authors’ supervisor or superior but, rather, the individual who will be responsible for corresponding with the Journal in the process of revising the manuscript; in most cases this is the first author himself or herself.

3.4 Abstract. (on a separate page)

We use structured abstracts for original articles that include the following sections:

Background(current state of knowledge about subject and/or why the current study is important);

Hypothesis/Aim (specific question that will be resolved by the study);

Method (sample selection and procedures);

Results (primary and secondary outcomes);

Conclusions (implication of the findings);

Trial Registration Number (if available for randomized controlled trials);

s should be written in the third person and be under 350 words in length. Most readers only scan the abstracts and many electronic search systems only provide abstracts, so the abstract needs to provide sufficient information for readers to determine what the problem was, what was done, what was found and the likely validity and generalizability of the results. All randomized controlled trials (RCTs) and case-control studies need to have a specific main hypothesis stated; other types of studies may have a hypothesis or an aim. Any statistical results provided in the abstract should include the test statistic, the degrees of freedom, and the p-value with three significant digits; do not present a p-value without the corresponding test statistic. Important values that are main findings should be presented with 95% confidence intervals. Do not, however, overburden the results section of the abstract with numbers and statistics; present the main results with supporting statistics but limit the use of statistics when describing secondary results.

Following international standards we strongly recommend that researchers who plan to conduct randomized controlled clinical intervention trials register the studies on an international registry prior to starting patient enrollment for the study. The registration number for the study provided by the trial registry should then be put in the abstract following the discussion section. One such registry is (http:// prsinfo.clinicaltrials.gov/) but any registry that participates in the WHO Clinical Trial Registry Platform (http://www.who.int/ictrp/en/) including the Chinese Clinical Trial Registry (which is in Chinese) (http:// www.chictr.org/cn/) is acceptable. Most important international medical journals require registration of RCTs as a condition of acceptance for publication.

English-language manuscripts of original articles do not need to include a Chinese-language abstract and Chinese-language manuscripts do not need to include an English-language abstract. Chinese-language abstracts in Chinese manuscripts of original articles do, however, need to follow the structured format described above. Once the final revised and edited version of the English-language abstract is prepared for each article, the Journal office will prepare a final Chinese-language abstract that will be included at the end of the article. Similarly, an English-language abstract will be included at the end of the Chineselanguage version of the article that will be published in electronic form on the Journal website one month after release of the English-language version

Three to six key words that conform to MeSH requirements should follow the structured abstract. (see section 2.7).

3.5 Introduction.

The introduction must provide a clear overview of the current state of knowledge or research both in China and internationally. This should not be an exhaustive list of previous work but, rather, a summary of previous work emphasizing the theoretical, methodological, clinical or other problems that remain to be clarified or resolved. If there are existing systematic reviews or meta-analyses about the subject, these need to be cited. The authors must then indicate how the current research project will add to the sum of knowledge about the subject. For all RCTs and case-control studies the presumed theoretical relationship of the variables considered in the current project need to be specified and, based on this theoretical model, a main hypothesis should be presented that clearly specifies the main outcome variable and the methods that will be used to assess the outcome variable. Up to three secondary hypotheses can also be specified.

3.6 Methods.

Methods need to be described in sufficient detail such that a person knowledgeable in the field could replicate the study and such that readers can assess the reliability of the findings (i.e., internal validity) and the generalizability of the results (i.e., external validity). Research reports in China rarely provide this level of detail, so the methods section of submitted manuscripts will generally need to be longer than is typical for Chinese journals. The reporting guidelines mentioned above (in section 3.1) indicate the types of information needed for each type of study. Authors need to provide details about the source population for the study; about the procedures for selecting (sampling) individuals from the source population; about the randomization procedure (if there is one); about the diagnostic, evaluative and therapeutic procedures undertaken; and about the method used to assess the outcomes or other variables of interest in the study. In addition, the method section should include the following information:

• A brief statement about the sample size needed to address the primary hypothesis. (In most cases a detail computation of the required sample size is not needed).

• The numbers of individuals involved at each step of the project—selection, follow-up and outcome—should be specified in a ‘subject flowchart’ (see ‘Figures’ below).

• The basic characteristics of the final sample should be described. (In some cases this information can be put in the beginning of the results section.) If a substantial portion (10% or more) of potential subjects do not enter the study, the basic characteristics of those who are and are not included in the study should be compared. Similarly, if a substantial proportion of subjects enrolled in the study do not complete the study the characteristics of those who do and do not complete the study should be compared.

• The provenance (i.e., original source), source of the translated version, reliability, and validity of any questionnaires or other evaluative instruments used in the study need to be specified. If the study was done in China but the reliability and validity parameters of the employed scales are not available for China (a common problem) this should be stated and the current report should provide values (based on data collected in the study) that help readers assess these parameters (e.g., alpha values for the total score and subscale scores of scales that are used to assess outcomes).

• The origin of numerical values employed in the analysis and the theoretical range of such variables need to be specified. For example, if the total score of a scale is employed as a primary outcome measure the text could read: “The total score was the primary outcome measure employed; this was the sum of the 17 items in the scale (which were each scored 1-3) so the potential range of values of the total score was 17 to 51.” This information is needed so readers can understand the numerical values presented in the results and the relative importance of a reported change in mean scores.

• The methods of training persons who conduct the evaluations and their inter-rater reliability should be reported.

• The details of any novel laboratory procedures should be specified.

• The process of obtaining informed consent from subjects should be described and the institutional review board (or committee) that provided ethical approval for the study should be identified.

• For all research papers a figure presenting the flowchart for the enrollment and follow-up of subjects in the study needs to be prepared and placed after the references and before the tables in the manuscript. The figure should show the sampling frame from which the subjects were selected, reasons for non-inclusions and the numbers and reasons subjects drop out during the course of the study. Two examples are as follows:

3.6.1 Statistical methods

All the statistical tests employed in the primary and the secondary analyses should be specified and the software employed to conduct the analyses should also be specified. Authors need to ensure that the statistical tests employed are appropriate to the design and to the type of data available; avoid using chi square tests for ranked data, unpaired tests when paired tests are appropriate, and so forth. If the sample is weighted in the analysis the method of weighting the sample needs to be described. If any novel or uncommon statistical procedures are employed these need to be described in detail and references that describe the use of these methods should be provided. In general, for intervention studies intention-to-treat analyses (i.e., including data on ALL subjects who entered the study) are preferred to analyses that are limited to the subjects who complete the study. For intervention studies the main outcome measure should usually be the absolute difference between groups with a 95% confidence interval for the difference. When comparing multiple groups within a sample (e.g., mean total score of an outcome measure for four different treatment groups) multiple-comparison tests need to be used; it is not appropriate to simply report the overall statistic and assume all the groups are different from each other or to compute multiple bivariate tests on each pair of results.

The methods for categorizing outcome variables and other variables used in the analyses should be specified. For example, if a scale is used to assess ‘clinical improvement’ the cut-off score (or % improvement from baseline) for determining ‘improvement’ should be specified. Similarly, if a continuous variable is dichotomized or divided into multiple categories in the analysis, the method for doing so should be specified; for example, “…in the logistic regression analysis family income level was divided into ‘high’ and ‘low’ using the median value for the total sample”.

3.7Results.

The results of the primary analysis and any secondary analyses of interest should be presented, but secondary analyses should be clearly distinguished from those that are based ona priorihypotheses. Simple statistical results with only a few data points can be presented in the text but detailed data is often best presented in tables or – if a figure provides a clearer presentation of the data — in a figure. Data provided in the tables or figures can be summarized in the text but they should NOT be duplicated in the text. Main outcomes (e.g., prevalence, rate of improvement, odds ratios, etc.) should be presented with 95% confidence intervals. All p-values presented should be accompanied by the value for the corresponding statistical test and, in most cases, the degrees of freedom (e.g.,X2=0.95,df=2,p=0.301;t24=3.21,p=0.003). P-values should be presented with three significant figures (e.g.,p=0.172). The denominators for all percents and means presented should be specified unless it is clear from the text. Do not present new statistical methods in the results section, these should be described in the statistical section of the methods.

3.8 Discussion.

The discussion section for ALL research papers should be subdivided into the following three subsections: Main Findings, Limitations, and Significance.

3.8.1 Main findings

There should be a summary of the main findings as it relates to the original hypotheses. This is NOT a simple repetition of the results and does not usually need to repeat the numerical findings reported in the results. It is not appropriate to introduce new results that have not been reported in the results section. Avoid arriving at conclusions that are not justified by the results, such as assuming that a correlation identified in a cross-sectional study is a causal relationship. The relationship between existing evidence (prior studies) and the new findings of the current study should be clarified; but this should NOT be an exhaustive listing of all prior research, only prior work DIRECTLY relevant to the current results should be discussed.

3.8.2 Limitations

All factors that affect the accuracy of the findings should be mentioned and their potential affect on the study results discussed. Similarly factors that affect the representativeness of the findings and the generalizability of the results should be described and discussed.

3.8.3 Significance

The potential impact of the results on theoretical understanding of the condition, on clinical practice, and on the organization of health services should be described and future research that needs to be conducted to confirm or extend the results should be outlined. Do not claim to have‘discovered’ something if the data is only preliminary or if researchers in other locations have been conducting similar studies. Be conservative in making recommendations for changes in policy or practice, particularly if this study is the first one with this specific result or if the result is based on retrospective or cross-sectional data. Avoid overstating the importance of the results by making unfounded inferences and avoid making non-specific (i.e., empty) recommendations based on the results like ‘clinicians should be aware of the identified risk factors’ or ‘It is important to develop preventive programs for this problem’.

3.9 Acknowledgements.

Individuals who provided practical or strategic support for the study or in the preparation of the manuscript but do not meet the requirement of authorship should be mentioned. Their specific contribution can be described (simply) (e.g., ‘assisted in the data collection’, ‘assisted in the analysis’,‘provided valuable comments on a prior draft’, etc.). The lead author (or the corresponding author) must obtain the written consent of persons who are acknowledged (the editorial office may request this documentation during the review process). Institutions that supported the conduct of the study can also be mentioned, but the funding institution does not need to be mentioned because it is mentioned in a subsequent section.

3.10 Conflict of interest statement.

The presence of any financial or other conflict of interest by any of the named authors should be stated (and explained in the cover letter to the editors). If there is no conflict of interest of any of the authors this should be stated (e.g., ‘The authors report no conflict of interest related to this manuscript.’)

3.11 Funding.

If the study was supported by one or more research funds, the title and number of the grant(s) and the name of the institution(s) that provide grants or financial support to the authors to conduct, analyze or write-up the study should be specified. The role of the funder in the design, implementation, analysis and write-up of the study needs to be indicated. If there is no specific funding agency for the study this section should still be included in the manuscript and the statement ‘This study received no external funding.’

should be placed under the section heading.

3.12 References. (starting on a separate page)

See section 2.8.

3.13 Figures. (each figure is on a separate page, not inserted in the text of the results section)

See section 2.9. As described in section 3.6, all research articles must have a figure that shows enrollment and follow-up of subjects during the study. This is usually ‘Figure 1’. Other sequentially numbered figures are placed on separate pages in the manuscript after this study flowchart (before the tables). Diagrams and figures must be clearly labeled and provided in a form that will allow the editorial staff to re-format them for publication in the Journal.

3.14 Tables(each table is on a separate page, not inserted in the text of the results section)

See section 2.10. Tables are numbered sequentially as they appear in the text. If there is only one Table, it is still labeled as ‘Table 1’. Authors should check recent issues of theShanghai Archives of Psychiatryfor examples of how to format their tables.

3.15 Appendices. (each appendix is put on a separate page)

In some circumstances appendices will be included in the print version of an article. Articles that describe the reliability and validity of a new questionnaire or scale should usually have a copy of the final version of the scale in an appendix for the article. Details about laboratory methods or complex sampling strategies can also be placed in an appendix rather in the methods section. The editors will decide if such material goes in an appendix or should be placed on the website as supplemental materials.

4. SUBMISSION OF MANUSCRIPTS

The first author and corresponding author should read and comply with the ‘Shanghai Archives of Psychiatry Ethics Policy’ (http://www.saponline.org/en/Article/Detail/184?ssid=138) prior to submission of any manuscript. As indicated in this policy, theShanghai Archives of Psychiatryis a member of the Committee on Publication Ethics (COPE), ascribes to the ‘Code of Conduct and Best Practice Guidelines for Journal Editors’ and expects authors who submit manuscripts to the journal to be familiar with and follow the ethical requirements specified in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.

Manuscripts can be submitted on our website (www.saponline.org) or by e-mail directly to the editorial office (shtougao3296@163.com). We accept both Chinese-language and English-language manuscripts. The following documents should be included as part of each submission:

• COVER LETTER TO THE EDITORS. This brief letter (in WORD format) to the editors provides a list of the documents submitted, the reason this manuscript is considered appropriate for theShanghai Archives of Psychiatry,full contact information (e-mail and cell phone) for the corresponding author, the first author and, if different from the corresponding author, the individual who has access to the data set used to write the paper and who conducted the statistical analyses described in the paper. The cover letter can also include any additional information the authors wish to communicate about the submission. This letter should be signed by the first author and the corresponding author (if different from the first author).

• MANUSCRIPT.The full manuscript in WORD (.doc or docx) format. We strongly prefer to have all tables and figures inserted into a single document, not as separate documents.

• FIRST AUTHOR’S DECLARATION.The first author of all manuscripts submitted to the journal must complete theAuthor’s Declaration of Compliance with the Journal’s Ethics Policy(http://saponline. org/upload/2012/0929/A.pdf) and submit this signed form with the manuscript.

• AUTHORS’ STATEMENTS.Each named author must submit a separate ‘Statement of Authorship Form’(http://saponline.org/upload/2012/0929/C.pdf) which certifies that the material in the manuscript has not been published elsewhere, that it is not currently being considered by another journal, and that it will not be submitted for consideration at another journal while under consideration by theShanghai Archives of Psychiatry. All authors must also report on the form any financial or other potential conflicts of interest and indicate their level of participation in the preparation of the manuscript. Preferably the signed documents are scanned and submitted together as pdf files along with the manuscript, but if this is difficult to do because of the wide dispersal of authors or some other reason, these forms can also be submitted separately to the editorial office by e-mail or by fax (86(0)21-64685661).

• COPIES OF RELATED MANUSCRIPTS.If the authors (or other authors) have published or submitted a manuscript elsewhere on a similar topic using the same data set as the current manuscript, pdf files of these published papers and manuscripts need to be included with the submission so the editors can determine the amount of overlap between the submitted manuscript and previous publications.

• IRB APPROVAL.[Only for Original Research Articles]A copy of the document certifying Institutional Review Board approval (or its equivalent) for the study reported in the manuscript. This approval needs to indicate that the committee responsible agreed that the study met internationally accepted standards for the protection of the rights and safety of human subjects. Preferably the approval document is scanned and submitted as a pdf file along with the manuscript, but it can also be separately submitted to the editorial office by fax (86(0)21-64685661). If no IRB approval was obtained for the reported study this needs to be explained in the cover letter to the editor. All original articles need to include a statement about IRB review and acceptance of the study in the Methods section.

• AUTHOR’S DECLARATION REGARDING USE OF ANIMALS IN RESEARCH [Only for Original Research Articles that employ animals]If animals were used in the study the first author must certify that the study met all international standards regarding the use of animals in research by submitting the ‘Author’s Declaration Regarding Use of Animals in Research’ form (http://saponline.org/ upload/2012/0929/B.pdf).

• COPY OF CONSENT FORM FOR CASE REPORTS [Only for Case Reports]All submissions for the Case Reports section of the journal must be accompanied by a signed consent form from the individual(s) described in the report indicating their willingness to have the material published in a medical journal. Preferably the signed document is scanned and submitted as a pdf file along with the manuscript but the document can also be submitted separately to the editorial office by e-mail or by fax (86(0)21-64685661).

• SIGNED STATEMENT FROM INDIVIDUALS REFERRED TO IN THE ACKNOWLEDGMENT [If there are any]Inclusion of named individuals in an acknowledgment indirectly indicates that the named individuals approve of the manuscript. Persons named in an acknowledgment must agree that their name be used in this way. The first author or corresponding author must submit a copy of a signed statement from each individual named in the acknowledgment stating that they are willing to be named in the acknowledgment for the paper. Preferably the signed approvals are scanned and submitted as pdf files along with the manuscript but the documents can also be submitted separately to the editorial office by e-mail or by fax (86(0)21-64685661).

• INSTITUTIONAL APPROVAL. [Only for original research articles from mainland Chinese institutions]A signed document (in Chinese) from the first author’s institution needs to be submitted with manuscripts submitted from institutions in mainland China. In this document the authorities responsible for research at the institution certify that the manuscript has not been submitted elsewhere, that there is no conflict about the content of the manuscript among the authors, that the manuscript does not contain confidential data, and that the content is not plagiarized, fabricated or falsified. Author should obtain this document from the editorial office (shtougao3296@163.com). Preferably the signed document is scanned and submitted as a pdf file along with the manuscript, but it can be separately submitted to the editorial office by fax (86(0)21-64685661)

• SUPPLEMENTAL INFORMATION.Any supplemental information the authors would like the editors and reviewers to consider in the assessment of the manuscript.

5. THE REVIEW PROCESS

5.1Based on the agreement signed by all authors at the time of submission, authors arenotpermitted to submit the manuscript to other journals while it is under consideration by theShanghai Archives of Psychiatry. This is a legal agreement that all medical journals take seriously; authors who submit articles to multiple journals and their institutions are identified and entered on lists of delinquent authors and institutions. If, however, the corresponding author receives formal notification from the editorial office that the manuscript has been rejected, the authors are then permitted to submit it elsewhere.

5.2Manuscripts are initially assessed by editorial staff and (for original articles) a research methods reviewer and a biostatistical reviewer before being sent out for content review. Manuscripts that are clearly unsuitable for the Journal will be rejected without further review. If supplementary materials are not yet provided (e.g., conflict of interest statement by the authors) the authors will be asked to submit the required materials before the manuscript will be considered further. Within 14 working days of receipt of a manuscript authors will be informed about whether or not the manuscript will be considered for the Journal (this is NOT an acceptance of the paper).

5.3Authors of papers that will be considered will be informed of the formatting, methodological and statistical revisions needed before the manuscript will be sent out to our content reviewers. If authors have difficulty making the revisions recommended, the editorial office will do its best to assist the authors in making the necessary revisions. Authors who have not provided a revised version of the manuscript or corresponded with the editorial office about the manuscript for one month after the editorial office has requested the revisions will be notified by e-mail and telephone that the manuscript will be dropped from consideration by the Journal if a revision is not received within the next 10 days.

5.4When a revised manuscript that satisfactorily addresses the issues raised by the editorial reviewers is received it will be sent to two content reviewers for a blinded evaluation.

5.5If both reviewers recommend rejection the manuscript will be rejected. If both reviewers recommend acceptance, it will be conditionally accepted. If there is disagreement from the two reviewers the manuscript will be sent to a third reviewer for an independent assessment; if the third reviewer recommends rejection it will be rejected, if the third reviewer recommends acceptance it will be conditionally accepted.

5.6Conditionally accepted manuscripts will be reviewed by the editorial management group (including members of the editorial board) which makes the final decision on acceptance or rejection of allmanuscripts. In most cases ‘acceptance’ by the editorial review group will be dependent on the authors’willingness and ability to make additional revisions based on the recommendations of the content experts and the editors.

5.7Authors of papers that are ‘accepted’ by the editorial management group will be asked to make additional revisions or additions to their manuscripts based on the comments of the reviewers and the editors. If necessary, editorial staff will assist authors in making the requested revisions, which often require new, more sophisticated analyses of the data. If the subsequently submitted revised version of the manuscript is considered by the editorial office to adequately address the issues raised by reviewers, the authors will be formally notified that the manuscript has been accepted for publication. At this time the first author will be asked to submit a picture and a brief biosketch that will be included in the publication.

5.8If the revised manuscript does not resolve major problems identified by the reviewers and the authors are unable or unwilling to make the requested changes, the paper will be rejected. Authors who have not provided a revised version or corresponded with the editorial office about the manuscript for six weeks after the editorial office requests these revisions will be notified by e-mail and telephone that the manuscript will be dropped from consideration by the Journal if a revision is not received within the next 10 days.

5.9In most cases this review process is completed within three months of receipt of the revised manuscript (following the initial review by the editorial office). If the review process takes longer than three months the editorial office will contact the corresponding author and tell him or her about the current status of the manuscript.

5.10Authors of papers that are rejected will be sent the reviews from the content experts.

5.11Revised manuscripts submitted in Chinese will be translated into English by editorial staff. The revised English-language manuscripts will then be line-edited by a native English-speaking editor. This detailed process of translation often results in further revisions to the text and identifies additional problems with the manuscript. Multiple interactions (either by e-mail or phone) with the author and, if different, the individual responsible for the analysis, are usually needed to resolve these issues and arrive at a final English-language version of the original Chinese-language manuscript.

5.12The final English-language version of the manuscript will be typeset and a proof in pdf format will be sent to the corresponding author for checking and approval.

5.13Once the typeset proof has been corrected and approved by the corresponding author it will be converted into a doi version and placed on the website for the journal as an ‘in press’ manuscript so that it can be made freely available prior to publication in the paper version of the Journal. The typeset version of the manuscript will also be placed in the cue to be published in the paper version of the journal.

5.14The final English-language version will be translated into Chinese, typeset and released on the Journal’s Chinese-language website one month after publication of the English-language version. Prior to placing the Chinese version on the website a PDF of the article will be sent to the authors (if the author group includes Chinese-speaking members) for approval.

6. FAST-TRACK SUBMISSION

We provide a fast-track option for authors who can justify the need for rapid publication of their results. Authors who wish to have their manuscripts considered for fast-track publication should indicate this in the cover letter to the editor that accompanies the manuscript. If we agree to fast-track a publication and the authors are able to provide rapid revisions based on reviewers’ comments, we will endeavor to place a doi version of the manuscript on our website within one month of receipt of the manuscript.